Mr. Robert Lee Steele Iv, PA-C Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1757 Highway 178 W Ste A, Myrtle, MS 38650 Phone: 662-988-7041 |
News Archive
In Tuesday's health section of The New York Times, "When a Drug Addict Isn't Ready to Accept Help" and "In Business, Nondrinking Can Be a Costly Expense," both articles address the harsh realities of what happens when addiction hits home.
Helicobacter pylori (H. pylori) is the causal agent of chronic gastritis, ulcer and gastric cancer. It has the potential to persist in the human stomach for decades, sometimes causing neither harm nor clinical symptoms. Nevertheless, on some occasions, depending on the host immune system and the strain causing the infection, the outcome can be very serious. To maintain the infection, the bacterium must adapt to survive the host defences. One way to accomplish this is to sequentially change the external proteins on the bacterial surface.
VBL Therapeutics today announced positive preclinical results evaluating VB-201 for the treatment of psoriasis. VB-201 is a first-in-class, orally administered immune response modifier expected to reduce inflammation by targeting key pro-inflammatory cytokines. Today's data suggest that VB-201 has significant anti-inflammatory properties that are active against psoriasis; an ongoing Phase 2 efficacy and safety study is currently evaluating VB-201 for the treatment of patients with psoriasis.
Biomedical engineers at UC Davis have developed a microfluidic chip to test for latent tuberculosis. They hope the test will be cheaper, faster and more reliable than current testing for the disease.
› Verified 4 days ago